LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

McKesson Corp

Затворен

СекторЗдравеопазване

941.35 -0.23

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

935.73

Максимум

947.74

Ключови измерители

By Trading Economics

Приходи

40M

1.3B

Продажби

3B

106B

P/E

Средно за сектора

27.175

61.417

Дивидентна доходност

0.33

Марж на печалбата

1.177

Служители

43,000

EBITDA

374M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+5.97% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.33%

2.40%

Следващи печалби

7.05.2026 г.

Следваща дата на дивидент

1.04.2026 г.

Следваща дата на екс-дивидент

1.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

11B

116B

Предишно отваряне

941.58

Предишно затваряне

941.35

Настроения в новините

By Acuity

41%

59%

107 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.03.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15.03.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13.03.2026 г., 19:08 ч. UTC

Значими събития в новините

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

15.03.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15.03.2026 г., 23:44 ч. UTC

Пазарно говорене
Значими събития в новините

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15.03.2026 г., 23:35 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15.03.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15.03.2026 г., 22:37 ч. UTC

Пазарно говорене

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15.03.2026 г., 22:18 ч. UTC

Пазарно говорене

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15.03.2026 г., 22:00 ч. UTC

Значими събития в новините

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15.03.2026 г., 22:00 ч. UTC

Значими събития в новините

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15.03.2026 г., 03:00 ч. UTC

Значими събития в новините

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14.03.2026 г., 15:00 ч. UTC

Значими събития в новините

Iran War Delivers Windfall to America's Oil Country -- WSJ

14.03.2026 г., 02:03 ч. UTC

Печалби

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14.03.2026 г., 01:32 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14.03.2026 г., 00:29 ч. UTC

Придобивния, сливания и поглъщания

13D Filings -- Barrons.com

13.03.2026 г., 22:27 ч. UTC

Пазарно говорене
Значими събития в новините

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13.03.2026 г., 22:13 ч. UTC

Пазарно говорене
Значими събития в новините

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13.03.2026 г., 22:04 ч. UTC

Пазарно говорене
Значими събития в новините

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13.03.2026 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

13.03.2026 г., 20:50 ч. UTC

Пазарно говорене
Значими събития в новините

Financial Services Roundup: Market Talk

13.03.2026 г., 20:02 ч. UTC

Пазарно говорене

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13.03.2026 г., 19:50 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13.03.2026 г., 19:35 ч. UTC

Значими събития в новините

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

5.97% нагоре

12-месечна прогноза

Среден 997.1 USD  5.97%

Висок 1,107 USD

Нисък 885 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

9

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

107 / 351 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat